# Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer

> **NCT02046538** · PHASE2 · WITHDRAWN · sponsor: **Weill Medical College of Cornell University**

## Conditions studied

- Adenocarcinoma of the Colon
- Adenocarcinoma of the Rectum

## Interventions

- **DRUG:** Leucovorin
- **DRUG:** Oxaliplatin
- **DRUG:** 5-FU
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT02046538
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-02
- **Primary completion:** 2016-02
- **Final completion:** 2018-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigator terminated due to funding issues
- **Last updated:** 2017-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02046538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02046538, "Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02046538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*